Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,726 | -7,375 | 4,096 | -54,818 | -30,659 |
| Depreciation Amortization | 271 | 180 | 92 | 367 | 283 |
| Other Working Capital | 3,654 | 2,884 | 1,702 | 5,200 | 3,277 |
| Other Operating Activity | -19,086 | -1,750 | -6,334 | 33,355 | 15,700 |
| Operating Cash Flow | $-11,435 | $-6,061 | $-444 | $-15,896 | $-11,399 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,001 | 502 | N/A | 2,577 | 2,393 |
| Investing Cash Flow | $2,001 | $502 | $N/A | $2,577 | $2,393 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 166 | 141 | -28 | 27,784 | 26,914 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -235 |
| Financing Cash Flow | $166 | $141 | $-28 | $27,784 | $26,679 |
| Beginning Cash Position | 29,375 | 29,375 | 29,375 | 14,910 | 14,910 |
| End Cash Position | 20,107 | 23,957 | 28,903 | 29,375 | 32,583 |
| Net Cash Flow | $-9,268 | $-5,418 | $-472 | $14,465 | $17,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,435 | -6,061 | -444 | -15,896 | -11,399 |
| Free Cash Flow | -11,435 | -6,061 | -444 | -15,896 | -11,399 |